あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/22 | 1,080 | 1,104 | 1,080 | 1,101 | +11 | +1% | 32,600 |
| 2022/09/21 | 1,112 | 1,112 | 1,086 | 1,090 | -35 | -3.1% | 53,500 |
| 2022/09/20 | 1,121 | 1,137 | 1,121 | 1,125 | +4 | +0.4% | 25,300 |
| 2022/09/16 | 1,140 | 1,141 | 1,118 | 1,121 | -24 | -2.1% | 36,700 |
| 2022/09/15 | 1,166 | 1,166 | 1,141 | 1,145 | -12 | -1% | 24,800 |
| 2022/09/14 | 1,153 | 1,182 | 1,151 | 1,157 | -42 | -3.5% | 45,400 |
| 2022/09/13 | 1,192 | 1,206 | 1,178 | 1,199 | +10 | +0.8% | 41,100 |
| 2022/09/12 | 1,188 | 1,193 | 1,174 | 1,189 | +10 | +0.8% | 34,800 |
| 2022/09/09 | 1,160 | 1,190 | 1,154 | 1,179 | +17 | +1.5% | 71,600 |
| 2022/09/08 | 1,138 | 1,166 | 1,138 | 1,162 | +31 | +2.7% | 50,400 |
| 2022/09/07 | 1,133 | 1,139 | 1,117 | 1,131 | -16 | -1.4% | 42,100 |
| 2022/09/06 | 1,147 | 1,162 | 1,139 | 1,147 | -4 | -0.3% | 36,100 |
| 2022/09/05 | 1,134 | 1,157 | 1,127 | 1,151 | +10 | +0.9% | 32,900 |
| 2022/09/02 | 1,161 | 1,163 | 1,137 | 1,141 | -20 | -1.7% | 41,200 |
| 2022/09/01 | 1,170 | 1,177 | 1,160 | 1,161 | -25 | -2.1% | 47,400 |
| 2022/08/31 | 1,190 | 1,192 | 1,175 | 1,186 | -19 | -1.6% | 53,700 |
| 2022/08/30 | 1,205 | 1,216 | 1,196 | 1,205 | +12 | +1% | 35,900 |
| 2022/08/29 | 1,197 | 1,217 | 1,160 | 1,193 | -40 | -3.2% | 132,000 |
| 2022/08/26 | 1,239 | 1,243 | 1,219 | 1,233 | -6 | -0.5% | 34,300 |
| 2022/08/25 | 1,231 | 1,250 | 1,231 | 1,239 | +11 | +0.9% | 33,000 |
| 2022/08/24 | 1,223 | 1,234 | 1,210 | 1,228 | -10 | -0.8% | 47,700 |
| 2022/08/23 | 1,253 | 1,254 | 1,232 | 1,238 | -18 | -1.4% | 46,400 |
| 2022/08/22 | 1,249 | 1,269 | 1,230 | 1,256 | +4 | +0.3% | 59,000 |
| 2022/08/19 | 1,270 | 1,270 | 1,242 | 1,252 | -14 | -1.1% | 67,900 |
| 2022/08/18 | 1,229 | 1,277 | 1,216 | 1,266 | +37 | +3% | 138,000 |
| 2022/08/17 | 1,183 | 1,235 | 1,152 | 1,229 | +41 | +3.5% | 115,700 |
| 2022/08/16 | 1,204 | 1,204 | 1,181 | 1,188 | -27 | -2.2% | 55,400 |
| 2022/08/15 | 1,235 | 1,235 | 1,182 | 1,215 | -7 | -0.6% | 118,300 |
| 2022/08/12 | 1,195 | 1,226 | 1,190 | 1,222 | +38 | +3.2% | 152,100 |
| 2022/08/10 | 1,172 | 1,194 | 1,140 | 1,184 | +19 | +1.6% | 166,800 |
| 2022/08/09 | 1,143 | 1,179 | 1,117 | 1,165 | +64 | +5.8% | 264,400 |
| 2022/08/08 | 1,099 | 1,105 | 1,085 | 1,101 | +10 | +0.9% | 97,700 |
| 2022/08/05 | 1,061 | 1,094 | 1,061 | 1,091 | +36 | +3.4% | 56,100 |
| 2022/08/04 | 1,051 | 1,063 | 1,044 | 1,055 | +7 | +0.7% | 49,400 |
| 2022/08/03 | 1,069 | 1,069 | 1,040 | 1,048 | -20 | -1.9% | 67,300 |
| 2022/08/02 | 1,092 | 1,092 | 1,065 | 1,068 | -25 | -2.3% | 45,500 |
| 2022/08/01 | 1,070 | 1,095 | 1,062 | 1,093 | +28 | +2.6% | 49,300 |
| 2022/07/29 | 1,073 | 1,073 | 1,058 | 1,065 | -8 | -0.7% | 49,700 |
| 2022/07/28 | 1,073 | 1,080 | 1,057 | 1,073 | +10 | +0.9% | 57,700 |
| 2022/07/27 | 1,055 | 1,070 | 1,049 | 1,063 | +4 | +0.4% | 46,400 |
| 2022/07/26 | 1,080 | 1,080 | 1,055 | 1,059 | -20 | -1.9% | 45,200 |
| 2022/07/25 | 1,068 | 1,080 | 1,065 | 1,079 | +12 | +1.1% | 30,700 |
| 2022/07/22 | 1,065 | 1,076 | 1,051 | 1,067 | -1 | -0.1% | 27,600 |
| 2022/07/21 | 1,051 | 1,068 | 1,048 | 1,068 | +9 | +0.8% | 42,400 |
| 2022/07/20 | 1,055 | 1,063 | 1,054 | 1,059 | +6 | +0.6% | 70,200 |
| 2022/07/19 | 1,057 | 1,057 | 1,040 | 1,053 | -4 | -0.4% | 26,700 |
| 2022/07/15 | 1,051 | 1,059 | 1,044 | 1,057 | +9 | +0.9% | 26,700 |
| 2022/07/14 | 1,050 | 1,053 | 1,040 | 1,048 | -9 | -0.9% | 29,300 |
| 2022/07/13 | 1,060 | 1,071 | 1,056 | 1,057 | +6 | +0.6% | 38,000 |
| 2022/07/12 | 1,057 | 1,079 | 1,036 | 1,051 | -11 | -1% | 82,800 |
701～
750
件表示中 / 1062件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 246,300円 | +16.9% | +33.2% | 2.23% | 13.43倍 | 1.07倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ハートシード | 355,500円 | +174.2% | - | 0.00% | - | 10.76倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| ＪＣＲファーマ | 60,000円 | +14.3% | - | 3.33% | 24.39倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ヘリオス | 63,700円 | +150.0% | - | 0.00% | - | 33.79倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| タウンズ | 53,100円 | +4.6% | +6.1% | 5.27% | 9.06倍 | 3.36倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム
